LGS Gut Therapy - Complete and Gentle Acute Care
Texto original en francés.
Producto de salud natural autorizado en Canadá
Si este producto se vendiera en Francia
- Conditions légales
Foeniculum vulgare Mill.: La portion journalière recommandée ne doit pas conduire à une ingestion d'estragole supérieure à 0,05 mg/kg de poids corporel pour les enfants de moins de 12 ans.
arrêté du 24 juin 2014, annexe I. Órdenes francesas de 9 de mayo de 2006 (nutrientes), 24 de junio de 2014 (plantas) y 26 de septiembre de 2016 (otras sustancias), fondo LEGI consolidado, consultado el 23 de octubre de 2026.
- Conditions légales
Linum usitatissimum L.: L'étiquetage doit comporter un avertissement déconseillant l'usage chez les femmes ayant des antécédents personnels ou familiaux de cancer du sein.
arrêté du 24 juin 2014, annexe I. Órdenes francesas de 9 de mayo de 2006 (nutrientes), 24 de junio de 2014 (plantas) y 26 de septiembre de 2016 (otras sustancias), fondo LEGI consolidado, consultado el 23 de octubre de 2026.
Solo se calcula una cantidad diaria para una posología oral explícita para adultos, expresada por día y en una unidad sólida correspondiente a la forma del producto. No se extrapolan las unidades ambiguas, los líquidos, los polvos ni las dosis pediátricas. Una cantidad no calculada no se compara con los límites de dosis. Este análisis no constituye una autorización de venta en Francia ni una evaluación de seguridad o eficacia.
Composición
| Ingrediente medicinal y fuente | Por unidad posológica, según la fuente | Máximo diario, adulto |
|---|---|---|
| Bifidobacterium animalis subsp. Lactis Fuente : Cellule entière | 9.280.000.000 ufc | No calculada |
| Bifidobacterium animalis subsp. Lactis Fuente : BL-04 | 9.280.000.000 ufc | No calculada |
| Protéase fongique Fuente : Aspergillus flavus var. oryzae - En entier Potencia : 11.000 FCC HUT | 10,45 milligramme | No calculada |
| 4-(1,3;1,4)-bêta-D-glucane 4-glucanohydrolase Fuente : Trichoderma longibrachiatum - En entier Potencia : 1.800 FCC CU | 6,2 milligramme | No calculada |
| Triacylglycérol lipase Fuente : Rhizopus oryzae - En entier Potencia : 40 FCC LU | 0,08 milligramme | No calculada |
| Papaïne Fuente : Carica papaya - fruit Potencia : 62.500 FCC PU | 25 milligramme | No calculada |
| Mentha x piperita Fuente : Extrait de Feuille Relación de extracción : 10:1 Equivalente de planta seca : 400 milligramme | 40 milligramme | No calculada |
| Foeniculum vulgare subsp. vulgare var. dulce Fuente : Seed extract Relación de extracción : 4:1 Equivalente de planta seca : 400 milligramme | 100 milligramme | No calculada |
| Lactobacillus plantarum Fuente : Cellule entière | 880.000.000 ufc | No calculada |
| Lactobacillus plantarum Fuente : Lp-115 | 880.000.000 ufc | No calculada |
| Lactobacillus acidophilus Fuente : Cellule entière | 13.740.000.000 ufc | No calculada |
| Lactobacillus acidophilus Fuente : LA-14 | 13.740.000.000 ufc | No calculada |
| Huile de poisson Fuente : Huile du corps d'Anchois Potencia : 18 % DHA (docosahexaenoic acid) | 833,33 milligramme | No calculada |
| Huile de poisson Fuente : Huile du corps d'Anchois Potencia : 48 % EPA (eicosapentaenoic acid) | No especificada | No calculada |
| Curcuma longa Fuente : Rhizome Extract Relación de extracción : 4:1 Equivalente de planta seca : 400 milligramme | 100 milligramme | No calculada |
| Linum usitatissimum L. (Linaceae) Fuente : Graine(s) | 100 milligramme | No calculada |
| Bifidobacterium longum subsp. longum Fuente : Cellule entière | 220.000.000 ufc | No calculada |
| Bifidobacterium longum subsp. longum Fuente : BI-05 | 220.000.000 ufc | No calculada |
| Lactobacillus casei Fuente : LC-11 | 440.000.000 ufc | No calculada |
| Lactobacillus casei Fuente : Cellule entière | 440.000.000 ufc | No calculada |
| Lactobacillus rhamnosus Fuente : Cellule entière | 440.000.000 ufc | No calculada |
| Lactobacillus rhamnosus Fuente : LR-32 | 440.000.000 ufc | No calculada |
| Bromélaïne de tige Fuente : Ananas comosus var. comosus - Tige Potencia : 600.000 FCC PU | 25 milligramme | No calculada |
| Inuline Fuente : Cichorium intybus - racine | 2.500 milligramme | No calculada |
| L-Glutamine Fuente : L-Glutamine | 2.500 milligramme | No calculada |
| Althaea officinalis Fuente : Racine | 250 milligramme | No calculada |
| Plantago afra Fuente : Graine(s) | 1.250 milligramme | No calculada |
| Acacia Fuente : Gomme | 500 milligramme | No calculada |
| Protéase Fuente : Aspergillus niger - En entier Potencia : 34 FCC SAPU | 6,42 milligramme | No calculada |
| 4-alpha-D-Glucane glucanohydrolase Fuente : Aspergillus flavus var. oryzae - Cellule entière Potencia : 3.700 FCC DU | 16,54 milligramme | No calculada |
| 1,4-alpha-D-Glucane glucohydrolase Fuente : Aspergillus niger Potencia : 22 FCC AGU | 16,32 milligramme | No calculada |
Ingredientes no medicinales
Huile de tournesol, Hypromellose, Acide citrique, Feuille de stevia rebaudiana, Maltodextrine, Saveur, Dextrine, farine de riz, gomme acacia, Eau purifiée, Dioxyde de silicium, Son de riz, cellulose, Lécithine, Glycérine, bêta-carotène, Cire d'abeille, Gomme de xanthane, Caramel, Gélatine, Carbonate de calcium
Dosis recomendadas en Canadá
| Población | Edad | Cantidad por toma | Frecuencia |
|---|---|---|---|
| Adultes | Non précisée | 1 Capsule, libération retardée | 1 Tous les jours |
| Adultes | Non précisée | 3 Gélule | Non précisée |
| Adultes | Non précisée | 2 Mesures | Non précisée |
| Adultes | Non précisée | 1 Capsule | 3 Tous les jours |
Usos autorizados en Canadá
Inflammation Support: Source of omega-3 fatty acids for the maintenance of good health. Source of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). Used in Herbal Medicine to aid digestion. Used in Herbal Medicine to help relieve flatulent dyspepsia (carminative). Used in Herbal Medicine as a hepatoprotectant / liver protectant. Used in Herbal Medicine to increae bile excretion by the liver (choleretic) and stimulate contraction of the gallbladder (cholagogue). Used in Herbal Medicine as an anti-inflammatory to help relieve joint pain. Healing Fibre: (Used in Herbal Medicine as a) bulk-forming laxative. (Used in Herbal Medicine to) promote(s) bowel movements by increasing bulk volume and water content. (Used in Herbal Medicine to) provide(s) gentle relief of constipation and / or irregularity. Helps restore plasma glutamine levels depleted after periods of physical stress (e.g. prolonged exhaustive exercise). Helps support immune system health after periods of physical stress. Helps support digestive system health after periods of physical stress. Helps to assist in muscle cell repair after exercise. Source of fibre for the maintenance of good health. Helps support and maintain a health digestive system. Helps stimulate the growth of healthy bacteria (such as bifidobacteria) in the intestine / gut. Prebiotic. Helps provide gentle relief of constipation and / or irregularity. Acute Care Probiotic: Source of probiotics. Helps support intestinal / gastrointestinal health. Could promote a favourable gut flora. Intensive Enzymes: Digestive enzyme. Digestive aid. Helps digest proteins. Sweet Fennel is traditionally used in Herbal Medicine to help relieve digestive disturbances including bloating and flatulence. Sweet Fennel is traditionally used in Herbal Medicine to help relieve the pain associated with menstruation. Sweet Fennel is traditionally used in Herbal Medicine as an expectorant to help relieve coughs associated with colds. Peppermint is traditionally used in Herbal Medicine to aid digestion (stomachic). Peppermint is traditionally used in Herbal Medicine to help relieve flatulent dyspepsia ( Carminative).
Texto original en inglés.
Un uso autorizado en Canadá no es una declaración de propiedades saludables autorizada en la Unión Europea. Consulte el registro de declaraciones de propiedades saludables.
Advertencias en Canadá
Cautions and Warnings : Inflammation Support: Consult a health care practitioner prior to use if you are pregnant or have gallstones, a bile duct obstruction, stomach ulcers or excess stomach acid. Consult a health care practitioner if symptoms persist or worsen. Store in an airtight containter, protected from light. Healing Fibre: Take 2 hours before or after taking other medications or natural health products since the absorption of these products may be delayed. Effects observed 12-24 hours after first does, and may take 2-3 days. Consult a health care practitioner if symptoms persist, worsen or if laxative effect does not occur within seven days. Consult a health care practitioner immediately if you experience chest pain, vomiting, or difficulty in swallowing or breathing after taking this product. Consult a health care practitioner prior to use if you are pregnant or breastfeeding or following a low protein diet or taking medications which inhibit peristaltic movement (e.g. opioids, loperamide) or have diabetes or have symptoms such as abdominal pain, nausea, vomiting or fever (as these could be signs of abnormal constrictions of the gastrointestinal tract, diseases of the oesophagus and/or the superior opening of the stomach (cardia), potential or existing intestinal blockage, paralysis of the intestine, megacolon, faecal impaction, inflamed bowel or appendicitis). Do not use if experiencing a sudden change in bowel habits that has persisted for more than 2 weeks, undiagnosed rectal bleeding, or failure to defaecate following the use of another laxative product or have diabetes mellitus in which blood sugar is difficult to regulate or have difficulty swallowing. Hypersensitivity, such as allergy, has been known to occur due to flaxseed and inulin and also following inhaled and/or ingested psyllium; in which case, discontinue use. May cause mild gastro-intestinal discomfort (such as gas, bloating, cramps). Store in well-closed containers at room temperature. Acute Care Probiotic: If you have fever, vomiting, bloody diarrhoea or severe abdominal pain, consult a health care practitioner prior to use. If symptoms of digestive upset (e.g. diarrhea) occur, worsen, or persist beyond 3 days, discontinue use and consult a health care practitioner. If you have an immune-compromised condition (e.g. AIDS, lymphoma, patients undergoing long-term corticosteroid treatment), do not use this product. Intensive Enzymes: Consult a health care practitioner for use beyond 2 weeks. Consult a health care practitioner if symptoms persist or worsen. Consult a health care practitioner prior to use if you are pregnant or breastfeeding, have anemia, gallstones, a gastrointestinal lesion/ulcer, diabetes or allergy to latex or fruits (such as avocado, banana, chestnut, passion fruit, fig, melon, mango, kiwi, pineapple, peach and tomato), are taking an anticoagulant/blood thinner, anti-nflammatory or antibiotic, or are having surgery. Do not use if you are allergic to anethole or plants of the Apiaceae / Carrot family. Hypersensitivity/allergy has been known to occur ; in which case, discontinue use. Nausea, vomiting and diarrhoea have been known to occur, in which case discontinue use (and consult a health care practitioner).
Texto original en inglés.
Ficha del producto
- Otros nombres
- LGS Gut Therapy Step 1: Complete and Gentle Acute Care
- Titular
- Lifeagen Biosciences of Florida, Inc. dba Nu-Life North America
- NPN o DIN-HM
- 80077529
- Estado
- Licencia activa
- Fecha de licencia
- 17 de mayo de 2017
- Fecha de revisión
- No indicada
- Forma
- Gélule
- Vía de administración
- Orale
- Tipo de solicitud
- Non traditionnelle
Fuente
Ficha oficial de Health Canada, licencia 80077529
Base de datos de productos de salud natural autorizados (BDPSNH), Health Canada: productos autorizados, ingredientes, dosis, usos y advertencias, consultado el 27 de octubre de 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Texto original en inglés.
Texto original en francés.
La fórmula vendida en Europa con el mismo nombre puede ser diferente. Esta información no sustituye el consejo de un médico o farmacéutico.
Advertencias oficiales (Health Canada)
Health Canada publica advertencias sobre estos ingredientes:
- Mentha x piperita
Leer la advertencia, cuándo se aplica y los estudios citados
Texto original oficial en inglés.
PEPPERMINT - MENTHA X PIPERITA
Vía de administración: Oral
Precauciones y advertencias
Condición de aplicación: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have gallstones or anemia (Brinker 2010; Mills and Bone 2005; Blumenthal et al. 2000).
Fuentes citadas por Health Canada (3)
- Blumenthal M, Goldberg A, Brinkmann J, editors. Herbal Medicine: Expanded Commission E Monographs. Boston (MA): Integrative Medicine Communications; 2000.
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- Mills S, Bone K. The Essential Guide to Herbal Safety. St. Louis (MO): Elsevier Churchill Livingstone; 2005.
Condición de aplicación: Essential oil.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have hiatus hernia or gastroesophageal reflux (Brinker 2010; Mills and Bone 2005; ESCOP 2003).
Fuentes citadas por Health Canada (3)
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- ESCOP 2003: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (UK): European Scientific Cooperative on Phytotherapy and Thieme; 2003.
- Mills S, Bone K. The Essential Guide to Herbal Safety. St. Louis (MO): Elsevier Churchill Livingstone; 2005.
Reacciones adversas conocidas
Condición de aplicación: Essential oil.
When using this product you may experience gastroesophageal reflux (Brinker 2010; Mills and Bone 2005; ESCOP 2003).
Fuentes citadas por Health Canada (3)
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- ESCOP 2003: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (UK): European Scientific Cooperative on Phytotherapy and Thieme; 2003.
- Mills S, Bone K. The Essential Guide to Herbal Safety. St. Louis (MO): Elsevier Churchill Livingstone; 2005.
Stop use if hypersensitivity/allergy occurs (Mills and Bone 2005; ESCOP 2003).
Fuentes citadas por Health Canada (2)
- ESCOP 2003: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (UK): European Scientific Cooperative on Phytotherapy and Thieme; 2003.
- Mills S, Bone K. The Essential Guide to Herbal Safety. St. Louis (MO): Elsevier Churchill Livingstone; 2005.
- Foeniculum vulgare subsp. vulgare var. dulce
Leer la advertencia, cuándo se aplica y los estudios citados
Texto original oficial en inglés.
BITTER FENNEL- FOENICULUM VULGARE
Vía de administración: Oral
Precauciones y advertencias
Condición de aplicación: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (EMA 2024, 2007).
Fuentes citadas por Health Canada (2)
- EMA 2024. European Medicines Agency. Community Monograph on Foeniculum vulgare Miller subs. vulgare var. vulgare. London (UK): EMA Committee on Herbal Medicinal Products (HMPC), 31 January 2024. [Accessed 2024 March 14]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-foeniculum-vulgare-miller-subsp-vulgare-var-vulgare-fructus_en.pdf
- EMA 2007. European Medicines Agency. Community Monograph on Foeniculum vulgare Miller subs. vulgare var. vulgare oil. London (UK): EMA Committee on Herbal Medicinal Products (HMPC), 5 July 2007. [Accessed 2024 March 1]. Available from: http://www.e-lactancia.org/media/papers/Fennel-DS-EMEA2007.pdf
Condición de aplicación: Essential oil and Tincture.
Ask a health care practitioner before use if you are taking any medications including birth control pills or hormone therapy or other health products (EMA 2007).
Fuentes citadas por Health Canada (1)
- EMA 2007. European Medicines Agency. Community Monograph on Foeniculum vulgare Miller subs. vulgare var. vulgare oil. London (UK): EMA Committee on Herbal Medicinal Products (HMPC), 5 July 2007. [Accessed 2024 March 1]. Available from: http://www.e-lactancia.org/media/papers/Fennel-DS-EMEA2007.pdf
Reacciones adversas conocidas
Stop use if hypersensitivity/allergy occurs (EMA 2024, 2007).
Fuentes citadas por Health Canada (2)
- EMA 2024. European Medicines Agency. Community Monograph on Foeniculum vulgare Miller subs. vulgare var. vulgare. London (UK): EMA Committee on Herbal Medicinal Products (HMPC), 31 January 2024. [Accessed 2024 March 14]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-foeniculum-vulgare-miller-subsp-vulgare-var-vulgare-fructus_en.pdf
- EMA 2007. European Medicines Agency. Community Monograph on Foeniculum vulgare Miller subs. vulgare var. vulgare oil. London (UK): EMA Committee on Herbal Medicinal Products (HMPC), 5 July 2007. [Accessed 2024 March 1]. Available from: http://www.e-lactancia.org/media/papers/Fennel-DS-EMEA2007.pdf
Monografía de Health Canada del 29 de noviembre de 2024
SWEET FENNEL -FOENICULUM VULGARE
Vía de administración: Oral
Precauciones y advertencias
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (EMA 2024).
Fuentes citadas por Health Canada (1)
- EMA 2024. European Medicines Agency. Community Monograph on Foeniculum vulgare Miller. subsp. vulgare var. dulce (Mill.) Batt. & Trab., Fructus London (UK): EMA Committee on Herbal Medicinal Products (HMPC), 31 January 2024. [Accessed 2024 March 14]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-european-union-herbal-monograph-foeniculum-vulgare-miller-subsp-vulgare-var-dulce-mill-batt-trab-fructus-revision-1_en.pdf
Reacciones adversas conocidas
Stop use if hypersensitivity/allergy occurs (EMA 2024).
Fuentes citadas por Health Canada (1)
- EMA 2024. European Medicines Agency. Community Monograph on Foeniculum vulgare Miller. subsp. vulgare var. dulce (Mill.) Batt. & Trab., Fructus London (UK): EMA Committee on Herbal Medicinal Products (HMPC), 31 January 2024. [Accessed 2024 March 14]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-european-union-herbal-monograph-foeniculum-vulgare-miller-subsp-vulgare-var-dulce-mill-batt-trab-fructus-revision-1_en.pdf
- Huile de poisson
Leer la advertencia, cuándo se aplica y los estudios citados
Texto original oficial en inglés.
FISH OIL
Vía de administración: Oral
Precauciones y advertencias
Condición de aplicación: Pain of rheumatoid arthritis.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen.
Condición de aplicación: Healthy mood balance.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have psychological disorders such as anxiety or depression.
- Curcuma longa
Leer la advertencia, cuándo se aplica y los estudios citados
Texto original oficial en inglés.
TURMERIC - CURCUMA LONGA - Oral
Vía de administración: Oral (ESCOP 2003; Blumenthal et al. 2000)
Precauciones y advertencias
Condición de aplicación: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (ESCOP 2003; Brinker 2001; McGuffin et al. 1997).
Fuentes citadas por Health Canada (2)
- ESCOP: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (GB): European Scientific Cooperative on Phytotherapy and Thieme; 2003.
- McGuffin M, Hobbs C, Upton R, Goldberg A, editors. American Herbal Products Association's Botanical Safety Handbook. Boca Raton (FL): CRC Press; 1997.
1 estudio citado en el texto no tiene referencia correspondiente en la monografía (véanse las anomalías en la página de fuentes).
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a liver or biliary disorder (HC 2025; EMA 2018; Brinker 2010; ESCOP 2003; McGuffin et al. 1997).
Fuentes citadas por Health Canada (6)
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- EMA 2018. European Medicines Agency. European Union herbal monograph on Curcuma longa L., rhizome. London (GB): EMA Committee on Herbal Medicinal Products (HMPC); 25 September 2018. [Accessed 2023 October 14] Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-european-union-herbal-monograph-curcuma-longa-l-rhizoma-revision-1_en.pdf
- ESCOP: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (GB): European Scientific Cooperative on Phytotherapy and Thieme; 2003.
- HC 2025: Health Canada: Summary Safety Review - Turmeric and Curcuminoids for Oral Use - Assessing the Potential Risk of Hepatotoxicity. Available from: https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR1758121117867
- McGuffin M, Hobbs C, Upton R, Goldberg A, editors. American Herbal Products Association's Botanical Safety Handbook. Boca Raton (FL): CRC Press; 1997.
- SC 2025: Santé Canada : Résumé de l'examen de l'innocuité - Curcuma et curcuminoïdes pour usage oral - Évaluation du risque potentiel d'hépatotoxicité. Disponible à : https://pmps.hpfb-dgpsa.ca/documents-d-examen/ressource/SSR1758121117867
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking medications (HC 2025).
Fuentes citadas por Health Canada (2)
- HC 2025: Health Canada: Summary Safety Review - Turmeric and Curcuminoids for Oral Use - Assessing the Potential Risk of Hepatotoxicity. Available from: https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR1758121117867
- SC 2025: Santé Canada : Résumé de l'examen de l'innocuité - Curcuma et curcuminoïdes pour usage oral - Évaluation du risque potentiel d'hépatotoxicité. Disponible à : https://pmps.hpfb-dgpsa.ca/documents-d-examen/ressource/SSR1758121117867
Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if you experience any new symptoms including yellowing of the eyes or skin, dark urine, nausea, vomiting, stomach pain (HC 2025).
Fuentes citadas por Health Canada (2)
- HC 2025: Health Canada: Summary Safety Review - Turmeric and Curcuminoids for Oral Use - Assessing the Potential Risk of Hepatotoxicity. Available from: https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR1758121117867
- SC 2025: Santé Canada : Résumé de l'examen de l'innocuité - Curcuma et curcuminoïdes pour usage oral - Évaluation du risque potentiel d'hépatotoxicité. Disponible à : https://pmps.hpfb-dgpsa.ca/documents-d-examen/ressource/SSR1758121117867
Condición de aplicación: All uses except for Source of antioxidants and Hepatoprotectant.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Monografía de Health Canada del 26 de septiembre de 2025
Turmeric -CURCUMA LONGA - Topical
Precauciones y advertencias
For external use only.
When using this product avoid contact with eyes. If contact occurs, rinse thoroughly with water.
Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen or last (for) more than 7 days.
Keep out of reach of children. If swallowed, call a poison control centre or get medical help right away.
Contraindicaciones
Do not use on deep or puncture wounds, animal bites or serious burns.
- Linum usitatissimum L. (Linaceae)
Leer la advertencia, cuándo se aplica y los estudios citados
Texto original oficial en inglés.
FLAXSEED - LINUM USITATISSIMUM
Vía de administración: Oral
Precauciones y advertencias
Se aplica a los productos: providing 5 g or more of flaxseed per day.
Ask a health care practitioner/health care provider/health care professional/doctor/physician immediately if you experience chest pain, vomiting, or difficulty swallowing or breathing after taking this product (EMA 2015).
Fuentes citadas por Health Canada (1)
- EMA 2015. European Medicines Agency. European Union Herbal Monograph on Linum usitatissimum L., semen. London (GB): EMA Committee on Herbal Medicinal Products (HMPC), 10 March 2015. [Accessed 2023 December 31]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-linum-usitatissimum-l-semen_en.pdf
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have diabetes or a lazy bowel (EMA 2015; ESCOP 2003).
Fuentes citadas por Health Canada (2)
- EMA 2015. European Medicines Agency. European Union Herbal Monograph on Linum usitatissimum L., semen. London (GB): EMA Committee on Herbal Medicinal Products (HMPC), 10 March 2015. [Accessed 2023 December 31]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-linum-usitatissimum-l-semen_en.pdf
- ESCOP 2003: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (GB): European Scientific Cooperative on Phytotherapy and Thieme.
Condición de aplicación: Laxative; Promotion of bowel movement; Constipation.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen or if laxative effect does not occur within 7 days (Pray 2006; Repchinsky 2002).
Fuentes citadas por Health Canada (2)
- Pray WS. 2006. Non-Prescription Product Therapeutics, 2nd edition. New York (NY): Lippincott Williams & Wilkins.
- Repchinsky 2002: Canadian Pharmacists Association. Patient Self-Care. Helping Patients Make Therapeutic Choices. Ottawa (ON): Canadian Pharmacists Association.
Contraindicaciones
Se aplica a los productos: providing 5 g or more of flaxseed per day.
Do not use if you have difficulty swallowing (EMA 2015; ESCOP 2003).
Fuentes citadas por Health Canada (2)
- EMA 2015. European Medicines Agency. European Union Herbal Monograph on Linum usitatissimum L., semen. London (GB): EMA Committee on Herbal Medicinal Products (HMPC), 10 March 2015. [Accessed 2023 December 31]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-linum-usitatissimum-l-semen_en.pdf
- ESCOP 2003: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (GB): European Scientific Cooperative on Phytotherapy and Thieme.
Do not use if you have fever or any undiagnosed gastrointestinal trouble (EMA 2015; Gardner and McGuffin 2013; Brinker 2010; ESCOP 2003).
Fuentes citadas por Health Canada (4)
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- EMA 2015. European Medicines Agency. European Union Herbal Monograph on Linum usitatissimum L., semen. London (GB): EMA Committee on Herbal Medicinal Products (HMPC), 10 March 2015. [Accessed 2023 December 31]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-linum-usitatissimum-l-semen_en.pdf
- ESCOP 2003: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (GB): European Scientific Cooperative on Phytotherapy and Thieme.
- Gardner Z. and McGuffin M. editors. American Herbal Products Association's Botanical Safety Handbook, 2nd edition. American Herbal Products Association. Boca Raton (FL): CRC Press; 2013.
Reacciones adversas conocidas
Condición de aplicación: All products.
Stop use if hypersensitivity/allergy occurs (EMA 2015; León et al. 2003).
Fuentes citadas por Health Canada (2)
- EMA 2015. European Medicines Agency. European Union Herbal Monograph on Linum usitatissimum L., semen. London (GB): EMA Committee on Herbal Medicinal Products (HMPC), 10 March 2015. [Accessed 2023 December 31]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-linum-usitatissimum-l-semen_en.pdf
- León F, Rodríguez M, Cuevas M. 2003. Anaphylaxis to Linum. Allergologia et immunopathologia 31(1):47-49.
- L-Glutamine
Leer la advertencia, cuándo se aplica y los estudios citados
Texto original oficial en inglés.
L-Glutamine
Vía de administración: Oral
Precauciones y advertencias
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.
- Althaea officinalis
Leer la advertencia, cuándo se aplica y los estudios citados
Texto original oficial en inglés.
Marshmallow - ALTHAEA OFFICINALIS - Root
Vía de administración: Oral
Precauciones y advertencias
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.
Monografía de Health Canada del 19 de diciembre de 2025
MARSHMALLOW - ALTHAEA OFFICINALIS - LEAF
Vía de administración: Oral
Precauciones y advertencias
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.
Se refieren al ingrediente, no a este producto ni a su dosis. No sustituyen el consejo médico.
Se desconoce la fecha de la prueba de esta lista de ingredientes.
¿Ha cambiado el producto? Fotografíe el envase.
¿Alguna información inexacta o más reciente sobre este producto, sea usted lector o marca? Escriba a contact@compoatlas.com: cada corrección se publica en el registro de correcciones.